Patent: 11,957,324
Summary for Patent: 11,957,324
| Title: | Device and method for preparing and administering one-component fibrin sealant |
| Abstract: | Provided herein are systems for preparing and delivering fibrin sealant to a surface and methods of use thereof. In one embodiment, the system comprises: a. a quantity of a liquid mixture disposed within a container, the mixture comprising: I. fibrin or II. fibrinogen and Factor II; and b. a resin bed disposed within a vessel, the vessel capable of being in fluid communication with the container, wherein when in fluid communication, passage of the mixture through the vessel results in modification of the concentration of small molecules inhibitor(s) and/or inducer(s) within the mixture, favoring fibrin clot formation. |
| Inventor(s): | Ashley DeAnglis, Yair Pilpel, Yuri ZHERDEV, Sivan Doron, Lior Erez |
| Assignee: | Omrix Biopharmaceuticals Ltd , Ethicon Inc |
| Application Number: | US17/318,740 |
| Patent Claims: | see list of patent claims |
Details for Patent 11,957,324
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Omrix Biopharmaceuticals Ltd | CROSSEAL, EVICEL | fibrin sealant (human) | Spray | 125010 | March 21, 2003 | ⤷ Start Trial | 2041-05-12 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 11,957,324
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2015237745 | ⤷ Start Trial |
| Brazil | 112016022175 | ⤷ Start Trial |
| Canada | 2943928 | ⤷ Start Trial |
| China | 106456719 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
